Crystal structure of the avilamycin resistance-conferring methyltransferase AviRa from Streptomyces viridochromogenes

被引:8
作者
Mosbacher, TG
Bechthold, A
Schulz, GE
机构
[1] Univ Freiburg, Inst Organ Chem & Biochem, D-79104 Freiburg, Germany
[2] Univ Freiburg, Inst Pharmazeut Biol, D-79104 Freiburg, Germany
关键词
antibiotic resistance; rRNA-methyltransferase; S-adenosyl-L-methionine; selenomethionine MAD; ribosome docking;
D O I
10.1016/S0022-2836(03)00407-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The emergence of antibiotic-resistant bacterial strains is a widespread problem in contemporary medical practice and drug design. It is therefore important to elucidate the underlying mechanism in each case. The methyltransferase AviRa from Streptomyces viridochromogenes mediates resistance to the antibiotic avilamycin, which is closely related to evernimicin, an oligosaccharide antibiotic that has been used in medical studies. The structure of AviRa was determined by X-ray diffraction at 1.5 Angstrom resolution. Phases were obtained from one selenomethionine residue introduced by site-directed mutagenesis. The chain-fold is similar to that of most methyltransferases, although AviRa contains two additional helices as a specific feature. A putative-binding site for the cofactor S-adenosyl-(L)-methionine was derived from homologous structures. It agrees with the conserved pattern of interacting amino acid residues. AviRa methylates a specific guanine base within the peptidyltransferase loop of the 23 S ribosomal RNA. Guided by the target, the enzyme was docked to the cognate ribosomal surface, where it fit well into a deep cleft without contacting any ribosomal protein. The two additional alpha-helices of AviRa filled a depression in the surface. Since the transferred methyl group of the cofactor is in a pocket beneath the enzyme surface, the targeted guanine base has to flip out for methylation. (C) 2003 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:147 / 157
页数:11
相关论文
共 48 条
[1]   Association between decreased susceptibility to a new antibiotic for treatment of human diseases, everninomicin (SCH 27899), and resistance to an antibiotic used for growth promotion in animals, avilamycin [J].
Aarestrup, FM .
MICROBIAL DRUG RESISTANCE, 1998, 4 (02) :137-141
[2]   Evernimicin (SCH27899) inhibits a novel ribosome target site: Analysis of 23S ribosomal DNA mutants [J].
Adrian, PV ;
Mendrick, C ;
Loebenberg, D ;
McNicholas, P ;
Shaw, KJ ;
Klugman, KP ;
Hare, RS ;
Black, TA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (11) :3101-3106
[3]   Mutations in ribosomal protein L16 conferring reduced susceptibility to evernimicin (SCH27899): Implications for mechanism of action [J].
Adrian, PV ;
Zhao, WJ ;
Black, TA ;
Shaw, KJ ;
Hare, RS ;
Klugman, KP .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (03) :732-738
[4]   THE CCP4 SUITE - PROGRAMS FOR PROTEIN CRYSTALLOGRAPHY [J].
BAILEY, S .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1994, 50 :760-763
[5]   A novel site of antibiotic action in the ribosome: Interaction of evernimicin with the large ribosomal subunit [J].
Belova, L ;
Tenson, T ;
Xiong, LQ ;
McNicholas, PM ;
Mankin, AS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (07) :3726-3731
[6]   Crystallography & NMR system:: A new software suite for macromolecular structure determination [J].
Brunger, AT ;
Adams, PD ;
Clore, GM ;
DeLano, WL ;
Gros, P ;
Grosse-Kunstleve, RW ;
Jiang, JS ;
Kuszewski, J ;
Nilges, M ;
Pannu, NS ;
Read, RJ ;
Rice, LM ;
Simonson, T ;
Warren, GL .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1998, 54 :905-921
[7]   RNA methylation under heat shock control [J].
Bügl, H ;
Fauman, EB ;
Staker, BL ;
Zheng, FH ;
Kushner, SR ;
Saper, MA ;
Bardwell, JCA ;
Jakob, U .
MOLECULAR CELL, 2000, 6 (02) :349-360
[8]   RNA:(guanine-N2) methyltransferases RsmC/RsmD and their homologs revisited -: bioinformatic analysis and prediction of the active site based on the uncharacterized Mj0882 protein structure -: art. no. 10 [J].
Bujnicki, JM ;
Rychlewski, L .
BMC BIOINFORMATICS, 2002, 3 (1)
[9]   AVILAMYCIN [J].
BUZZETTI, F ;
EISENBERG, F ;
GRANT, HN ;
KELLERSC.W ;
VOSER, W ;
ZAHNER, H .
EXPERIENTIA, 1968, 24 (04) :320-+
[10]   Crystal structure of an initiation factor bound to the 30S ribosomal subunit [J].
Carter, AP ;
Clemons, WM ;
Brodersen, DE ;
Morgan-Warren, RJ ;
Hartsch, T ;
Wimberly, BT ;
Ramakrishnan, V .
SCIENCE, 2001, 291 (5503) :498-501